| Filed On | Filing |
|---|---|
| 26 Oct 2026 | EFFECT |
| 21 Oct 2026 | AMENDMENT NO. 1 TO FORM S-3 |
| 21 Oct 2026 | AMENDMENT NO. 1 TO FORM 10-Q |
| 16 Oct 2026 | DEFINITIVE ADDITIONAL MATERIALS |
| 16 Oct 2026 |
8-K: Other Events
As previously disclosed in that Current Report on Form 8-K filed by Adial Pharmaceuticals, Inc. (the “Company”) with the Securities and Exchange Commission (the “SEC”) on September 18, 2026, on September 17, 2026, the Company convened it... |
| 05 Oct 2026 | DEFINITIVE ADDITIONAL MATERIALS |
| 02 Oct 2026 |
8-K: Other Events
As previously disclosed in that Current Report on Form 8-K filed by Adial Pharmaceuticals, Inc. (the “Company”) with the Securities and Exchange Commission (the “SEC”) on September 18, 2026, on September 17, 2026, the Company convened it... |
| 21 Sep 2026 |
Form 4: Young Wendy B., Director
Granted 25,666 Stock Option (Right to Buy) |
| 18 Sep 2026 | DEFINITIVE ADDITIONAL MATERIALS |
| 18 Sep 2026 |
8-K: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers; Submission of Matters to a Vote of Security Holders
(a) Successor to Prior Plan. The Plan is the successor to the Prior Plan. As of the Effective Date, (i) no additional awards may be granted under the Prior Plan; and (ii) all outstanding awards granted under the Prior Plan will remain su... |
| 16 Sep 2026 | DEFINITIVE ADDITIONAL MATERIALS |
| 16 Sep 2026 |
8-K: Entry into a Material Definitive Agreement; Other Events
The following unaudited pro forma condensed financial information presents the historical unaudited consolidated balance sheet as of June 30, 2026 of Adial Pharmaceuticals, Inc. (“Adial” or the “Company”), adjusted to give effect to (i) ... |
| 28 Aug 2026 | REGISTRATION STATEMENT |
| 28 Aug 2026 | REGISTRATION STATEMENT |
| 25 Aug 2026 | 8-K: Unregistered Sales of Equity Securities |
| 24 Aug 2026 | FORM ARS |
| 24 Aug 2026 |
Proxy statement: annual meeting on September 17, 2026
CEO pay $891K, down 26% |
| 21 Aug 2026 | 8-K: Notice of Delisting or Failure to Satisfy a Listing Rule |
| 17 Aug 2026 | 8-K: Results of Operations and Financial Condition |
| 14 Aug 2026 | QUARTERLY REPORT |
Loading...
